网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
叶酸及维生素B12联合西酞普兰对卒中后抑郁高血浆同型半胱氨酸水平患者的疗效
作者:胡锦全  
单位:湖北省十堰市太和医院
关键词:叶酸 维生素B12 卒中后抑郁 疗效 
分类号:
出版年·卷·期(页码):2015·43·第四期(450-452)
摘要:

目的 观察叶酸、维生素B12联合西酞普兰治疗卒中后抑郁患者的治疗效果。方法 90例卒中后抑郁患者分为A、B两组(每组n=45),两组患者均给予缺血性脑卒中常规治疗,A组给予西酞普兰片20mg/d口服,B组在口服西酞普兰基础上加用叶酸5mg/d及维生素B120.5mg/d口服。检测患者治疗前及治疗12周后血浆同型半胱氨酸(homocysteine, Hcy)水平,采用汉密尔顿抑郁量表(HAMD)评估患者的抑郁状况,采用临床神经功能缺损评分(CSS)评价患者神经功能状况。结果 治疗12周后,A组患者血浆Hcy水平无明显变化,B组患者血浆Hcy水平明显下降,两组患者HAMD及CSS评分均较治疗前下降,B组患者的HAMD及CSS评分显著低于A组,差异具有统计学意义(P<0.05)。结论 叶酸、维生素B12联合西酞普兰治疗卒中后抑郁能够显著降低患者血浆Hcy水平,改善抑郁状况,促进神经功能的恢复,疗效优于单用西酞普兰。

Objective To observe the therapeutic effect of folic acid and vitamin B12 combined with citalopram for post-stroke depression. Methods Ninety cases of patients with post-stroke depression were divided into two groups(group A and B) (n=45). Both group A and B were given the conventional treatment of ischemic. Group A received citalopram 20mg/d, group B received folic acid 0.4 mg/d and vitamin B12 0.5 mg/d combined with citalopram. Plasma Hcy were measured before treatment and at the end of 12 weeks of treatment, depression of patients were evaluated with Hamilton Depression Scale (HAMD), clinic nerve function defect score(CSS) were assessed for the patients’ neurological function. Results After 12 weeks, Hcy level in group A haven’t significantly changed(P>0.05), while the Hcy level were significantly decreased in group B(P>0.05), the score of HAMD and CSS in group B were significantly lower than those in group A. Conclusions Folic acid and vitamin B12 combined with citalopram can decrease the Hcy level, improve the symptom of depress and promote the neurological function recovery in the treatment of post-stroke depression. It takes effects better than citalopram alone.

参考文献:
服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 752508 位访问者


 ©《现代医学》编辑部
联系电话:025-83272481;83272479
电子邮件: xdyx@pub.seu.edu.cn

苏ICP备09058541